FDA device listing
Gamma Phage Lysis Assay for the Identification of Bacillus anthracis
FDA device listing 1310063962 · U.S. GOVERNMENT DEPARTMENT HHS
Key facts
| Proprietary names | Gamma Phage Lysis Assay for the Identification of Bacillus anthracis |
|---|---|
| Owner/operator | U.S. GOVERNMENT DEPARTMENT HHS |
| Owner/operator number | 1050190 |
| Premarket submissions | K143592 |
| Product codes | NVQ |
| Device names | NVQ - Bacteriophage And Controls, B. Anthracis Lysis |
| Device class | Class II |
| Classification regulations (21 CFR) | 866.3045 |
| Review panels | Microbiology |
| Registered establishments | CENTERS FOR DISEASE CONTROL AND PREVENTION |
| Establishment registrations | 1050190 |
| FEI numbers | 1050190 |
| Establishment operations | Complaint File Establishment, Manufacturer |
| Registration valid through | 2026 |
At a glance
- 1–9 Registered establishments listing this device
- None UDI devices (GUDID) under the same submission
- 1–9 Device listings citing the same submission
- Yes Premarket submission listed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA device listings
Establishments that make or process devices for the U.S. market must list each device with the FDA. A listing records the device's proprietary names, product codes and premarket submission, and every registered establishment that handles it.
Source: U.S. Food and Drug Administration (FDA), Establishment Registration and Device Listing database